Ketogenic Diet and Metabolic Therapies
Expanded Roles in Health and Disease
2. Auflage
Erschienen am 5. Juli 2022
Buch
Softcover
576 Seiten
978-0-19-750120-7 (ISBN)
Beschreibung
Ketogenic diets have treated epilepsy for nearly 100 years, yet metabolic therapy has remained obscure and underutilized for most of this time. In recent decades, the clinical efficacy of ketogenic therapy was confirmed definitively for pediatric epilepsy and has now expanded to adult epilepsy. Now, the benefits of metabolic therapy have been extended well beyond epilepsy to additional neurological, metabolic, and genetic disorders, and the importance of metabolic health is recognized as paramount.
This new edition of Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease highlights the growing research and clinical applications of metabolic therapies as effective in disease treatment, reversal and prevention. Emerging mechanisms include the landscape of the microbiome and epigenetics. Consistent with the first observations in 1921, in some cases metabolism-based strategies have proven equal or superior to pharmacological treatments for specific diseases and for treating multiple comorbidities.
This second edition commemorates the 100th anniversary of the ketogenic diet, shares new research in this rapidly moving field, and offers a valuable collection of high-resolution color figures. The team of editors for this edition have been working in this area for decades, and in this volume, they have assembled world leaders in this cutting-edge research. As the first academic, interdisciplinary book on ketogenic diet and metabolic therapy, this volume will be crucial during this time of increased appreciation for metabolic health in professionals and the public alike.
This new edition of Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease highlights the growing research and clinical applications of metabolic therapies as effective in disease treatment, reversal and prevention. Emerging mechanisms include the landscape of the microbiome and epigenetics. Consistent with the first observations in 1921, in some cases metabolism-based strategies have proven equal or superior to pharmacological treatments for specific diseases and for treating multiple comorbidities.
This second edition commemorates the 100th anniversary of the ketogenic diet, shares new research in this rapidly moving field, and offers a valuable collection of high-resolution color figures. The team of editors for this edition have been working in this area for decades, and in this volume, they have assembled world leaders in this cutting-edge research. As the first academic, interdisciplinary book on ketogenic diet and metabolic therapy, this volume will be crucial during this time of increased appreciation for metabolic health in professionals and the public alike.
Weitere Details
Auflage
2nd Revised edition
Sprache
Englisch
Verlagsort
New York
USA
Zielgruppe
Für Beruf und Forschung
Editions-Typ
Überarbeitete Ausgabe
Produkt-Hinweis
Broschur/Paperback
Klebebindung
Maße
Höhe: 255 mm
Breite: 178 mm
Dicke: 27 mm
Gewicht
1161 gr
ISBN-13
978-0-19-750120-7 (9780197501207)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben
E-Book
03/2022
2. Auflage
OUP eBook
67,49 €
Als Download verfügbar
E-Book
03/2022
2. Auflage
OUP eBook
67,49 €
Als Download verfügbar
Person
Susan A. Masino
Vernon D. Roosa Professor of Applied Science,
Trinity College
Vernon D. Roosa Professor of Applied Science,
Trinity College
Inhalt
1. General overview/introduction by co-editors, with a historical perspective
Section I. Ketogenic Diet for Epilepsy in the Clinic
2. Overview: Ketogenic Diets and Pediatric Epilepsy: An Update
3. 'Alternative' Ketogenic Diets
4. Ketogenic Diet Therapies in Adults: History, Demand, and Results
5. How Do You Implement the Diet?
6. Glut1 Deficiency Syndrome and the Ketogenic Dietary Therapies
7. Ketogenic Diet in Established Epilepsy Indications
8. Ketogenic Diet for Other Epilepsies
9. The Ketogenic Diets in Idiopathic Generalized Epilepsy Syndromes
10. Ketogenic Diet Therapy for Infants with Pharmacoresistant Epilepsy and/or Metabolic Disease
11. Ketogenic Diet in Status Epilepticus
12. Preventing Side Effects and Diet Discontinuation
Section II. Ketogenic Diet: Emerging Clinical Applications and Future Potential
13. Overview: Expanded Uses of Ketogenic Therapies
14. Metabolism-Based Treatments for Managing Cancer: Scientific Rationale
15. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
16. Ketogenic Diet, Social Behavior, and Autism: Insights from Animal Models
17. Ketotherapeutics to Rescue Brain Energy Deficits: An Emerging Strategy to Delay Cognitive Decline in Alzheimer's Disease
18. Ketogenic Diet and Ketones for Improving Neurological Outcomes after Acute Neurotrauma
19. Ketogenic Diets and Neuroinflammation
20. The Ketogenic Diet in the Treatment of Schizophrenia
21. The Ketogenic Diet and the Gut Microbiome
Section III. Ketogenic Diet in the Laboratory
22. Overview of Ketogenic Diet in the Laboratory: Progress on Models and Mechanisms
23. Ketogenic Diet and PPARy
24. Ketogenic Diet and Adenosine in Epilepsy - Models and Mechanisms
25. Ketogenic Diet and Epigenetic Mechanisms of Epileptogenesis
26. Ketogenic Diet, Aging, and Neurodegeneration
27. Metabolic Seizure Resistance via BAD and KATP Channels
28. Lactate Dehydrogenase: a Novel Metabolic Target
29. Effects of the Ketogenic Diet on the Blood-Brain Barrier
30. Metabolic and Redox Alterations by Ketogenic Diets
31. Nicotinamide Adenine Dinucleotide as a Central Mediator of the Ketogenic therapy
Section IV. Ketone-Based Metabolism: General Health and Metabolic Alternatives
32. Overview of Ketone-Based Metabolism: General Health and Metabolic Alternatives
33. Ketone Supplementation for Health and Disease
34. Neuroprotective and Behavioral Benefits of Exogenous Ketone Supplementation-evoked Ketosis
35. Amino Acids in the Treatment of Neurological Disorders
36. Identifying the Molecular Mechanism of the MCT (Ketogenic) Diet
37. Triheptanoin in Epilepsy and Beyond
38. Anti-seizure and Anti-epileptic Effects of Glycolysis Inhibition with 2-Deoxyglucose
39. Low Carbohydrate, Ketogenic Diets for the Treatment of Type 2 Diabetes and Obesity
40. Intermittent Exogenous Ketosis for Athletic Performance, Recovery and Adaptation
41. Advancing the Awareness and Application of Metabolic and Ketogenic Therapies Globally and Offering Hope
Section I. Ketogenic Diet for Epilepsy in the Clinic
2. Overview: Ketogenic Diets and Pediatric Epilepsy: An Update
3. 'Alternative' Ketogenic Diets
4. Ketogenic Diet Therapies in Adults: History, Demand, and Results
5. How Do You Implement the Diet?
6. Glut1 Deficiency Syndrome and the Ketogenic Dietary Therapies
7. Ketogenic Diet in Established Epilepsy Indications
8. Ketogenic Diet for Other Epilepsies
9. The Ketogenic Diets in Idiopathic Generalized Epilepsy Syndromes
10. Ketogenic Diet Therapy for Infants with Pharmacoresistant Epilepsy and/or Metabolic Disease
11. Ketogenic Diet in Status Epilepticus
12. Preventing Side Effects and Diet Discontinuation
Section II. Ketogenic Diet: Emerging Clinical Applications and Future Potential
13. Overview: Expanded Uses of Ketogenic Therapies
14. Metabolism-Based Treatments for Managing Cancer: Scientific Rationale
15. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
16. Ketogenic Diet, Social Behavior, and Autism: Insights from Animal Models
17. Ketotherapeutics to Rescue Brain Energy Deficits: An Emerging Strategy to Delay Cognitive Decline in Alzheimer's Disease
18. Ketogenic Diet and Ketones for Improving Neurological Outcomes after Acute Neurotrauma
19. Ketogenic Diets and Neuroinflammation
20. The Ketogenic Diet in the Treatment of Schizophrenia
21. The Ketogenic Diet and the Gut Microbiome
Section III. Ketogenic Diet in the Laboratory
22. Overview of Ketogenic Diet in the Laboratory: Progress on Models and Mechanisms
23. Ketogenic Diet and PPARy
24. Ketogenic Diet and Adenosine in Epilepsy - Models and Mechanisms
25. Ketogenic Diet and Epigenetic Mechanisms of Epileptogenesis
26. Ketogenic Diet, Aging, and Neurodegeneration
27. Metabolic Seizure Resistance via BAD and KATP Channels
28. Lactate Dehydrogenase: a Novel Metabolic Target
29. Effects of the Ketogenic Diet on the Blood-Brain Barrier
30. Metabolic and Redox Alterations by Ketogenic Diets
31. Nicotinamide Adenine Dinucleotide as a Central Mediator of the Ketogenic therapy
Section IV. Ketone-Based Metabolism: General Health and Metabolic Alternatives
32. Overview of Ketone-Based Metabolism: General Health and Metabolic Alternatives
33. Ketone Supplementation for Health and Disease
34. Neuroprotective and Behavioral Benefits of Exogenous Ketone Supplementation-evoked Ketosis
35. Amino Acids in the Treatment of Neurological Disorders
36. Identifying the Molecular Mechanism of the MCT (Ketogenic) Diet
37. Triheptanoin in Epilepsy and Beyond
38. Anti-seizure and Anti-epileptic Effects of Glycolysis Inhibition with 2-Deoxyglucose
39. Low Carbohydrate, Ketogenic Diets for the Treatment of Type 2 Diabetes and Obesity
40. Intermittent Exogenous Ketosis for Athletic Performance, Recovery and Adaptation
41. Advancing the Awareness and Application of Metabolic and Ketogenic Therapies Globally and Offering Hope